Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.

Torpe AH, Thorsen J, Mathiasen G, Iversen KF, Farmer S, Lund T, Hansen CT, Nielsen LK, Jørgensen NGD, Vase MØ, Teodorescu EM, Salomo M, Wennerström C, Slørdahl TS, Szabo AG

Open source

DOI: 10.1002/ajh.70383
Published: 2026 Aug
Container: American journal of hematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70383,
  title = {Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.},
  author = {Torpe AH and Thorsen J and Mathiasen G and Iversen KF and Farmer S and Lund T and Hansen CT and Nielsen LK and Jørgensen NGD and Vase MØ and Teodorescu EM and Salomo M and Wennerström C and Slørdahl TS and Szabo AG},
  year = {2026},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.70383},
  url = {https://doi.org/10.1002/ajh.70383}
}

RIS

TY  - JOUR
TI  - Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.
AU  - Torpe AH
AU  - Thorsen J
AU  - Mathiasen G
AU  - Iversen KF
AU  - Farmer S
AU  - Lund T
AU  - Hansen CT
AU  - Nielsen LK
AU  - Jørgensen NGD
AU  - Vase MØ
AU  - Teodorescu EM
AU  - Salomo M
AU  - Wennerström C
AU  - Slørdahl TS
AU  - Szabo AG
PY  - 2026
JO  - American journal of hematology
DO  - 10.1002/ajh.70383
UR  - https://doi.org/10.1002/ajh.70383
ER  -

APA

AH, T., J, T., G, M., KF, I., S, F., T, L., CT, H., LK, N., NGD, J., MØ, V., EM, T., M, S., C, W., TS, S., & AG, S. (2026). Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.. American journal of hematology. https://doi.org/10.1002/ajh.70383

Source records

pubmed · retrieved 2026-09-26T01:17:45.027Z